Sec. 207. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance.

80 words·~1 min read·/il/chapter-720/act-570/207

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Sec. 207. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule III if it finds that:

(1)the substance has a potential for misuse less than the substances listed in Schedule

I and II;

(2)the substance has currently accepted medical use in treatment in the United States;

and

(3)misuse of the substance may lead to moderate or low physiological dependence or high

psychological dependence.